€4.44
0.89% yesterday
Xetra, Dec 12, 05:35 pm CET
ISIN
DE000A0BL849
Symbol
V3V
Index
Sector
Industry

Vita 34 Stock price

€4.44
+0.48 12.12% 1M
-0.26 5.53% 6M
-0.80 15.27% YTD
-0.14 3.06% 1Y
-11.01 71.26% 3Y
-9.01 66.99% 5Y
-0.61 12.08% 10Y
Xetra, Closing price Thu, Dec 12 2024
-0.04 0.89%
ISIN
DE000A0BL849
Symbol
V3V
Index
Sector
Industry

Key metrics

Market capitalization €77.40m
Enterprise Value €77.59m
P/E (TTM) P/E ratio 29.98
EV/FCF (TTM) EV/FCF 8.12
EV/Sales (TTM) EV/Sales 0.96
P/S ratio (TTM) P/S ratio 0.96
P/B ratio (TTM) P/B ratio 3.19
Revenue growth (TTM) Revenue growth 7.73%
Revenue (TTM) Revenue €80.64m
EBIT (operating result TTM) EBIT €-3.45m
Free Cash Flow (TTM) Free Cash Flow €9.55m
Cash position €17.63m
EPS (TTM) EPS €0.15
P/E forward 44.40
P/S forward 0.94
EV/Sales forward 0.95
Show more

Is Vita 34 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,889 stocks worldwide.

Vita 34 Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Vita 34:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Vita 34:

Buy
100%

Financial data from Vita 34

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
81 81
8% 8%
100%
- Direct Costs 51 51
20% 20%
63%
30 30
177% 177%
37%
- Selling and Administrative Expenses 24 24
6% 6%
30%
- Research and Development Expense - -
-
-
5.36 5.36
136% 136%
7%
- Depreciation and Amortization 8.80 8.80
2% 2%
11%
EBIT (Operating Income) EBIT -3.45 -3.45
85% 85%
-4%
Net Profit 2.58 2.58
110% 110%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Vita 34 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vita 34 Stock News

EQS
16 days ago
Einstufung von Montega AG zu Vita 34 AG
EQS
21 days ago
Bei einer insgesamt positiven Geschäftsentwicklung bleibt die Situation in den einzelnen europäischen Märkten im Neukundengeschäft uneinheitlich. Wichtige Märkte wie Deutschland und Portugal zeigten im dritten Quartal weiterhin Schwäche, während sich die Schweiz, Spanien, Rumänien und – einmal me...
More Vita 34 News

Company Profile

Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells. The firm collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.

Head office Germany
CEO Jakub Baran
Employees 745
Founded 1997
Website www.vita34.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today